Cross Country Healthcare (CCRN) Proxy filing summary

Executive summary

• Agreement reached for acquisition by Knox Lane in an all-cash transaction valued at $437 million.

• Transaction aims to provide greater flexibility for investment in service, technology, and team development.

• No immediate changes to client support or personnel are anticipated as a result of the acquisition.

• Forward-looking statements highlight anticipated benefits and strategic rationale for the transaction.

Voting matters and shareholder proposals

• Shareholders will be asked to vote on the proposed acquisition at a meeting, with proxy materials to be distributed.

• Proxy statement and related documents will be filed with the SEC and made available to shareholders.

Board of directors and corporate governance

• Board considered various factors and expected benefits in approving the acquisition agreement.

• Directors and executive officers may participate in the solicitation of proxies for the transaction.